Mergers & Acquisitions Mergers & Acquisitions

Illumina’s challenge to EU review of Grail deal fast-tracked by judges

By Lewis Crofts
  • 03 Jun 2021 13:38
  • 03 Jun 2021 13:51
Illumina’s appeal against a European Commission decision to take jurisdiction over the company’s acquisition of cancer-detection company Grail will be fast-tracked through the bloc’s courts after judges decided to review the case under an “expedited procedure.”

The US gene-sequencing company is challenging the commission’s acceptance of a request from France that the deal

To view the latest version of this document and thousands of others like it, sign-in to MLex or register for a free trial.

Discover MLex

Stay on top of global regulatory developments

LEARN MORE LEARN MORE

Latest News